Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
Technology
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
Podjoint Logo
US
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/73/13/e2/7313e2ce-d507-1b40-d733-b9812fae62a9/mza_1033978978904189655.jpg/600x600bb.jpg
IDEA Collider
IDEA Pharma
54 episodes
9 months ago
A weekly podcast discussion about asymmetric learning - how organisations gain competitive advantage through their approach to learning, in all its forms. We will talk with thought leaders and experts to understand processes and systems of learning that lead to outperformance.
Show more...
Life Sciences
Business,
Management,
Marketing,
Science
RSS
All content for IDEA Collider is the property of IDEA Pharma and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
A weekly podcast discussion about asymmetric learning - how organisations gain competitive advantage through their approach to learning, in all its forms. We will talk with thought leaders and experts to understand processes and systems of learning that lead to outperformance.
Show more...
Life Sciences
Business,
Management,
Marketing,
Science
https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/73/13/e2/7313e2ce-d507-1b40-d733-b9812fae62a9/mza_1033978978904189655.jpg/600x600bb.jpg
IDEA Collider | Kabir Nath
IDEA Collider
52 minutes 11 seconds
4 years ago
IDEA Collider | Kabir Nath
An interview with Kabir Nath, President & CEO, Otsuka North America Pharmaceutical Business, covering innovation, Kabir's personal journey, culture, technology, books and more...
IDEA Collider
A weekly podcast discussion about asymmetric learning - how organisations gain competitive advantage through their approach to learning, in all its forms. We will talk with thought leaders and experts to understand processes and systems of learning that lead to outperformance.